About Index Trending news
Lists
Pricing
ImmusanT, Inc.

ImmusanT, Inc.

ImmusanT, Inc.

Immusan T is a biotechnology company focused on developing a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease.

Elsewhere

Alexa global traffic share

Twitter followers

13 Dec 2011
$20,000,000
Venture capital (Series A)